These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18200531)

  • 1. Proteins and peptides: strategies for delivery to and across the skin.
    Benson HA; Namjoshi S
    J Pharm Sci; 2008 Sep; 97(9):3591-610. PubMed ID: 18200531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedle-based drug delivery systems for transdermal route.
    Pierre MB; Rossetti FC
    Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging strategies for the transdermal delivery of peptide and protein drugs.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in transdermal drug delivery: A comprehensive review of physical penetration enhancement techniques.
    Gaikwad SS; Zanje AL; Somwanshi JD
    Int J Pharm; 2024 Mar; 652():123856. PubMed ID: 38281692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle system: a modulated approach for penetration enhancement.
    Khare N; Shende P
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1183-1192. PubMed ID: 34634991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcending the skin barrier to deliver peptides and proteins using active technologies.
    Singh N; Kalluri H; Herwadkar A; Badkar A; Banga AK
    Crit Rev Ther Drug Carrier Syst; 2012; 29(4):265-98. PubMed ID: 22746186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of proteins.
    Kalluri H; Banga AK
    AAPS PharmSciTech; 2011 Mar; 12(1):431-41. PubMed ID: 21369712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal drug delivery.
    Prausnitz MR; Langer R
    Nat Biotechnol; 2008 Nov; 26(11):1261-8. PubMed ID: 18997767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin.
    Gratieri T; Alberti I; Lapteva M; Kalia YN
    Eur J Pharm Sci; 2013 Dec; 50(5):609-22. PubMed ID: 23567467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical means of stratum corneum barrier manipulation to enhance transdermal drug delivery.
    Parhi R; Suresh P; Patnaik S
    Curr Drug Deliv; 2015; 12(2):122-38. PubMed ID: 24827915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective use of transdermal drug delivery in children.
    Delgado-Charro MB; Guy RH
    Adv Drug Deliv Rev; 2014 Jun; 73():63-82. PubMed ID: 24333231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive delivery of protein drugs through transdermal route.
    Chaulagain B; Jain A; Tiwari A; Verma A; Jain SK
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):472-487. PubMed ID: 29378433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal systems as drug delivery vehicles for dermal and transdermal applications.
    Pierre MB; Dos Santos Miranda Costa I
    Arch Dermatol Res; 2011 Nov; 303(9):607-21. PubMed ID: 21805180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming skin's barrier: the search for effective and user-friendly drug delivery.
    Prausnitz MR
    Diabetes Technol Ther; 2001; 3(2):233-6. PubMed ID: 11478330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment.
    Lee SH; Choi EH; Feingold KR; Jiang S; Ahn SK
    J Invest Dermatol; 1998 Jul; 111(1):39-43. PubMed ID: 9665384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmetic devices based on active transdermal technologies.
    Scott JA; Banga AK
    Ther Deliv; 2015; 6(9):1089-99. PubMed ID: 26389853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible skin permeabilization for transdermal delivery of macromolecules.
    Prausnitz MR
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):455-83. PubMed ID: 9450177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.